These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 33345329)

  • 1. Comprehensive mapping of immune tolerance yields a regulatory TNF receptor 2 signature in a murine model of successful Fel d 1-specific immunotherapy using high-dose CpG adjuvant.
    Leonard C; Montamat G; Davril C; Domingues O; Hunewald O; Revets D; Guerin C; Blank S; Heckendorn J; Jardon G; Hentges F; Ollert M
    Allergy; 2021 Jul; 76(7):2153-2165. PubMed ID: 33345329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CpG Adjuvant in Allergen-Specific Immunotherapy: Finding the Sweet Spot for the Induction of Immune Tolerance.
    Montamat G; Leonard C; Poli A; Klimek L; Ollert M
    Front Immunol; 2021; 12():590054. PubMed ID: 33708195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of bystander tolerance and immune deviation after Fel d 1 peptide immunotherapy.
    Moldaver DM; Bharhani MS; Rudulier CD; Wattie J; Inman MD; Larché M
    J Allergy Clin Immunol; 2019 Mar; 143(3):1087-1099.e4. PubMed ID: 29906527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleic acid vaccines and CpG oligodeoxynucleotides for allergen immunotherapy.
    Jacquet A
    Curr Opin Allergy Clin Immunol; 2021 Dec; 21(6):569-575. PubMed ID: 34387280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covalent coupling of vitamin D3 to the major cat allergen Fel d 1 improves the effects of allergen-specific immunotherapy in a mouse model for cat allergy.
    Grundström J; Neimert-Andersson T; Kemi C; Nilsson OB; Saarne T; Andersson M; van Hage M; Gafvelin G
    Int Arch Allergy Immunol; 2012; 157(2):136-46. PubMed ID: 21985799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The major cat allergen, Fel d 1, in diagnosis and therapy.
    Grönlund H; Saarne T; Gafvelin G; van Hage M
    Int Arch Allergy Immunol; 2010; 151(4):265-74. PubMed ID: 19844127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why is pet (cat/dog) allergen immunotherapy (AIT) such a controversial topic? Current perspectives and future directions.
    Liccardi G; Martini M; Bilò MB; Cecchi L; Milanese M; Brussino L; Motta E; Rogliani P
    Eur Ann Allergy Clin Immunol; 2024 Jul; 56(4):188-191. PubMed ID: 38348623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keep the cat, change the care pathway: A transformational approach to managing Fel d 1, the major cat allergen.
    Satyaraj E; Wedner HJ; Bousquet J
    Allergy; 2019 Oct; 74 Suppl 107(Suppl 107):5-17. PubMed ID: 31498459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological effects of adjuvanted low-dose allergoid allergen-specific immunotherapy in experimental murine house dust mite allergy.
    Heldner A; Alessandrini F; Russkamp D; Heine S; Schnautz B; Chaker A; Mwange J; Carreno Velazquez TL; Heath MD; Skinner MA; Kramer MF; Zissler UM; Schmidt-Weber CB; Blank S
    Allergy; 2022 Mar; 77(3):907-919. PubMed ID: 34287971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells.
    Palomares O; Akdis M; Martín-Fontecha M; Akdis CA
    Immunol Rev; 2017 Jul; 278(1):219-236. PubMed ID: 28658547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization of cats to induce neutralizing antibodies against Fel d 1, the major feline allergen in human subjects.
    Thoms F; Jennings GT; Maudrich M; Vogel M; Haas S; Zeltins A; Hofmann-Lehmann R; Riond B; Grossmann J; Hunziker P; Fettelschoss-Gabriel A; Senti G; Kündig TM; Bachmann MF
    J Allergy Clin Immunol; 2019 Jul; 144(1):193-203. PubMed ID: 31056187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoallergenic derivatives of Fel d 1 obtained by rational reassembly for allergy vaccination and tolerance induction.
    Curin M; Weber M; Thalhamer T; Swoboda I; Focke-Tejkl M; Blatt K; Valent P; Marth K; Garmatiuk T; Grönlund H; Thalhamer J; Spitzauer S; Valenta R
    Clin Exp Allergy; 2014 Jun; 44(6):882-94. PubMed ID: 24552249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of allergen-specific immunotherapy and allergen tolerance.
    Kucuksezer UC; Ozdemir C; Cevhertas L; Ogulur I; Akdis M; Akdis CA
    Allergol Int; 2020 Oct; 69(4):549-560. PubMed ID: 32900655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hypoallergenic cat vaccine based on Fel d 1-derived peptides fused to hepatitis B PreS.
    Niespodziana K; Focke-Tejkl M; Linhart B; Civaj V; Blatt K; Valent P; van Hage M; Grönlund H; Valenta R
    J Allergy Clin Immunol; 2011 Jun; 127(6):1562-70.e6. PubMed ID: 21411130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Der p 1-specific regulatory T-cell response during house dust mite allergen immunotherapy.
    Boonpiyathad T; Sokolowska M; Morita H; Rückert B; Kast JI; Wawrzyniak M; Sangasapaviliya A; Pradubpongsa P; Fuengthong R; Thantiworasit P; Sirivichayakul S; Kwok WW; Ruxrungtham K; Akdis M; Akdis CA
    Allergy; 2019 May; 74(5):976-985. PubMed ID: 30485456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections.
    Senti G; Crameri R; Kuster D; Johansen P; Martinez-Gomez JM; Graf N; Steiner M; Hothorn LA; Grönlund H; Tivig C; Zaleska A; Soyer O; van Hage M; Akdis CA; Akdis M; Rose H; Kündig TM
    J Allergy Clin Immunol; 2012 May; 129(5):1290-6. PubMed ID: 22464647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro evidence of efficacy and safety of a polymerized cat dander extract for allergen immunotherapy.
    Morales M; Gallego M; Iraola V; Taulés M; de Oliveira E; Moya R; Carnés J
    BMC Immunol; 2017 Feb; 18(1):10. PubMed ID: 28235411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking antibodies induced by allergen-specific immunotherapy ameliorate allergic airway disease in a human/mouse chimeric model.
    Vizzardelli C; Gindl M; Roos S; Möbs C; Nagl B; Zimmann F; Sexl V; Kenner L; Neunkirchner A; Zlabinger GJ; Pickl WF; Pfützner W; Bohle B
    Allergy; 2018 Apr; 73(4):851-861. PubMed ID: 29159964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune regulation by intralymphatic immunotherapy with modular allergen translocation MAT vaccine.
    Zaleska A; Eiwegger T; Soyer O; van de Veen W; Rhyner C; Soyka MB; Bekpen C; Demiröz D; Treis A; Söllner S; Palomares O; Kwok WW; Rose H; Senti G; Kündig TM; Ozoren N; Jutel M; Akdis CA; Crameri R; Akdis M
    Allergy; 2014 Sep; 69(9):1162-70. PubMed ID: 24934402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of major cat allergen Fel d 1 mimotopes on filamentous phage carriers.
    Luzar J; Molek P; Šilar M; Korošec P; Košnik M; Štrukelj B; Lunder M
    Mol Immunol; 2016 Mar; 71():176-183. PubMed ID: 26908079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.